🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to prospectively determine whether cap...
Status
Completed
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2007-05
Trial ID
NCT00838370
Treatments Being Tested
The purpose of this study was to demonstrate superiority of treatment with ...
Status
Completed
Location
Comprehensive Blood & Cancer Center
Start Date
2015-12-24
Trial ID
NCT02625610
The aim of BEVAMAINT is to improve benefic effect of maintenance therapy af...
Status
Active Not Recruiting
Location
Chu Dijon Bourgogne
Start Date
2020-01-27
Trial ID
NCT04188145
Treatments Being Tested
This clinical trial is designed to assess the efficacy and safety of the tr...
Status
Recruiting
Location
Yale Cancer Center
Start Date
2025-02-27
Trial ID
NCT06731478
Treatments Being Tested
In this study it will be determined whether the rate of severe toxicity ass...
Status
Completed
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2015-03
Trial ID
NCT02324452
Treatments Being Tested
This study was designed to compare the efficacy and safety of tislelizumab ...
Status
Completed
Location
University of California Davis Health System
Start Date
2018-12-13
Trial ID
NCT03777657
Treatments Being Tested
This trial will enroll patients with locally advanced rectal cancer (resect...
Status
Terminated
Location
Rocky Mountain Cancer Center
Start Date
2013-12
Trial ID
NCT02010567
Treatments Being Tested
The goal of this clinical trial is to establish guidelines for fluoropyrimi...
Status
Recruiting
Location
CHU Amiens
Start Date
2025-01-20
Trial ID
NCT06475352
Treatments Being Tested
The goal of this clinical trial is to test the safety of the trifluridine/t...
Status
Recruiting
Location
CHU Amiens
Start Date
2025-03-21
Trial ID
NCT06245356
Treatments Being Tested
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Status
Terminated
Location
Mayo Clinic Cancer Center
Start Date
2020-07-29
Trial ID
NCT04363801